<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01773902</url>
  </required_header>
  <id_info>
    <org_study_id>PfP3.2</org_study_id>
    <nct_id>NCT01773902</nct_id>
  </id_info>
  <brief_title>Protein for Premies</brief_title>
  <official_title>High Versus Standard Dose Protein for Very Preterm Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Although expressed breast milk is considered the optimal nutritional source for preterm
      infants, the macronutrient content is insufficient to enable optimal growth during neonatal
      intensive care. Optimal dose and optimal mode of administration (standardized or
      individualized) of enteral protein supplementation to very preterm infants have not been
      established.

      This study aims to compare the effects on weight gain of different modes of enteral protein
      supplementation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weight gain</measure>
    <time_frame>From birth - to the end of study intervention (anticipated to be on average 1 week before discharge home at approx 37 weeks PMA)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Head circumference growth</measure>
    <time_frame>From birth - to the end of study intervention (anticipated to be on average 1 week before discharge home at approx 37 weeks PMA)</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Plasma amino acid profile</measure>
    <time_frame>at 2 and 4 weeks after start of intervention</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Extreme Prematurity</condition>
  <arm_group>
    <arm_group_label>High Dose Protein (Individualized)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Protein supplementation according to breast milk content aiming for 4.5g/kg/d of enteral protein if &lt;1500g b.w. or 4.0g/kg/d of enteral protein if &gt;1500g b.w. until 1 week before discharge</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Dose Protein (Standardized)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Protein supplementation independent of individual breast milk content using a new high-dose-protein breast milk fortifier until 1 week before discharge</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard protein supplementation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Protein supplementation independent of individual breast milk content using a standard dose of a standard breast milk fortifier until 1 week before discharge</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>High Dose Protein (Individualized)</intervention_name>
    <description>Protein supplementation according to breast milk content aiming for 4.5g/kg/d of enteral protein if &lt;1500g b.w. or 4.0g/kg/d of enteral protein if &gt;1500g b.w. until 1 week before discharge</description>
    <arm_group_label>High Dose Protein (Individualized)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>High Dose Protein (Standardized)</intervention_name>
    <description>Protein supplementation independent of individual breast milk content using a new high-dose-protein breast milk fortifier until 1 week before discharge</description>
    <arm_group_label>High Dose Protein (Standardized)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Standard Protein Supplementation</intervention_name>
    <description>Protein supplementation independent of individual breast milk content using a standard-dose-protein breast milk fortifier until 1 week before discharge</description>
    <arm_group_label>Standard protein supplementation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  very preterm infants &lt;32 weeks gestation and &lt;1500g birth weight

          -  &gt; 100ml/kg/d of enteral feeding

        Exclusion Criteria:

          -  missing informed consent

          -  decision not to feed breast milk

          -  congenital malformations

          -  age &gt; 7 days at study entry
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>7 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Axel Franz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universität Tübingen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Children's Hospital Tuebingen</name>
      <address>
        <city>Tuebingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Maas C, Mathes M, Bleeker C, Vek J, Bernhard W, Wiechers C, Peter A, Poets CF, Franz AR. Effect of Increased Enteral Protein Intake on Growth in Human Milk-Fed Preterm Infants: A Randomized Clinical Trial. JAMA Pediatr. 2017 Jan 1;171(1):16-22. doi: 10.1001/jamapediatrics.2016.2681.</citation>
    <PMID>27893064</PMID>
  </results_reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 15, 2013</study_first_submitted>
  <study_first_submitted_qc>January 18, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 23, 2013</study_first_posted>
  <last_update_submitted>May 9, 2018</last_update_submitted>
  <last_update_submitted_qc>May 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Tuebingen</investigator_affiliation>
    <investigator_full_name>Axel Franz</investigator_full_name>
    <investigator_title>PD Dr. med.</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

